In stem cell transplant patients, dysgeusia can occur secondary to either chemotherapy/chemoradiation conditioning or graft-versus-host disease. Refer to the section on Dysgeusia in the section on Conditions Affected By Both Chemotherapy and Head/Neck Radiation in this summary for management recommendations.
In this article
This information is produced and provided by the National
Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National
Institute via the Internet web site at http://
.gov or call 1-800-4-CANCER.
WebMD Public Information from the National Cancer Institute
September 04, 2014
This information is not intended to replace the advice of a doctor.
Healthwise disclaims any liability for the decisions you make based on this